FdaApplication
NDA 021284
Identifiers
- fda_app_no: NDA021284
Properties
| Property | Value |
|---|---|
| applicant_name | SANDOZ INC |
| application_type | NDA |
| approval_date | 2002-06-05 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RITALIN LA | METHYLPHENIDATE HYDROCHLORIDE | 30MG | CAPSULE, EXTENDED RELEASE;ORAL |
| RITALIN LA | METHYLPHENIDATE HYDROCHLORIDE | 20MG | CAPSULE, EXTENDED RELEASE;ORAL |
| RITALIN LA | METHYLPHENIDATE HYDROCHLORIDE | 40MG | CAPSULE, EXTENDED RELEASE;ORAL |
| RITALIN LA | METHYLPHENIDATE HYDROCHLORIDE | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE, EXTENDED RELEASE;ORAL |
| RITALIN LA | METHYLPHENIDATE HYDROCHLORIDE | 10MG | CAPSULE, EXTENDED RELEASE;ORAL |
5 products